person · Reporting owner
Selvaraj Shelly Ramasamy
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | SVP Chief Information Officer | September 11, 2023 | September 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 11, 2023 · Filed September 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,453 |
Reported balance
After 2023-09-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-09-11 · Disposition to issuer · Disposed 2,045 · Balance 48,453 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 22,685 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Included in this number are 22,685 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2023 Filed Sep 12, 2023 19:58 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,045 | $105.25 | $215,241.16 |
DisclosureSEC source: 0001093557-23-000199 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,453 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 22,685 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| June 15, 2023 Filed Jun 15, 2023 21:16 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,115 | $130.00 | $274,952.96 |
DisclosureSEC source: 0001093557-23-000154 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,390 F1 · shares: On November 29, 2022, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| April 20, 2023 Filed Apr 20, 2023 22:39 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,007 | $125.00 | $250,875.00 |
DisclosureSEC source: 0001093557-23-000108 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,505 F1 · shares: On November 29, 2022, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,646 | $111.40 | $294,761.75 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,512 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,737 | $111.40 | $193,500.06 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,158 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:53 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,089 | $111.40 | $232,712.51 |
DisclosureSEC source: 0001093557-23-000083 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,895 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 20:57 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 10,885 | $0.00 | $10.89 |
DisclosureSEC source: 0001093557-23-000051 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,984 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 26,736 unvested restricted stock units, 10,885 of which were granted on March 8, 2023 and shall all vest on March 8, 2026, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:56 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 4,051 | $0.00 | $4.05 |
DisclosureSEC source: 0001093557-22-000157 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,942 F1 · shares: This RSU Award was granted pursuant to the Amended and Restated 2015 Equity Incentive Plan, in a transaction exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Adjusted to reflect Dexcom's 4-for-1 stock split, effective on June 10, 2022. Included in this number are 31,107 unvested restricted stock units, 4,051 of which were granted on September 8, 2022 and shall all vest on September 8, 2023, 11,556 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 8,192 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,308 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:21 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,366 | $401.27 | $949,404.82 |
DisclosureSEC source: 0001093557-22-000060 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,454 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 805 | $406.06 | $326,875.64 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 4 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,820 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 541 | $406.06 | $219,676.67 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,625 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 519 | $406.06 | $210,743.43 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,166 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:30 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,889 | $0.00 | $2.89 |
DisclosureSEC source: 0001093557-22-000054 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,685 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 6,764 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,827 of which were granted on March 8, 2020 and shall vest through March 8, 2023. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 18:12 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000258 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,764 F1 · shares: The transaction represents a gift by the Reporting Person of 250 shares to a charitable donor advised fund. F2 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 681 | $558.33 | $380,222.73 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 11 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,014 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 241 | $550.63 | $132,702.58 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 10 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,695 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F11 · price: This transaction was executed in multiple trades at prices ranging from $550.47 to $551.38. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 423 | $549.86 | $232,592.22 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 9 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,936 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $549.38 to $550.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 341 | $548.85 | $187,158.63 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 8 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,359 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $548.30 to $549.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 280 | $547.71 | $153,358.41 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 7 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,700 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $547.29 to $548.16. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 80 | $546.43 | $43,714.00 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 6 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,980 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $546.10 to $546.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 60 | $542.39 | $32,543.40 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 5 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,060 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $542.07 to $542.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 101 | $541.08 | $54,648.96 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 4 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,120 F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $540.65 to $541.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 8 | $542.94 | $4,343.52 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,221 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 689 | $541.36 | $372,997.04 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,229 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 04, 2021 Filed Sep 14, 2021 00:19 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,886 F1 · shares: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 22:41 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,867 | $355.86 | $664,390.62 |
DisclosureSEC source: 0001093557-21-000078 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,136 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,484 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 22:41 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,700 | $362.92 | $979,875.90 |
DisclosureSEC source: 0001093557-21-000078 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,003 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,484 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 00:29 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 152 | $356.94 | $54,254.88 |
DisclosureSEC source: 0001093557-21-000056 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,703 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 9,484 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 00:29 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 3,073 | $0.00 | $3.07 |
DisclosureSEC source: 0001093557-21-000056 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,855 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 9,484 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 29 | $405.33 | $11,754.57 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 8 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,753 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10 | $402.38 | $4,023.80 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 7 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,782 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 856 | $401.74 | $343,888.76 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 6 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,792 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $401.37 to $402.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 207 | $400.19 | $82,840.05 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 5 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,648 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $400.15 to $400.24. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,000 | $399.60 | $399,597.20 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 4 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,855 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $399.116 to $399.98. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 709 | $398.30 | $282,396.12 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,855 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 281 | $398.30 | $111,922.86 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,564 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 22:59 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,236 | $398.30 | $492,301.27 |
DisclosureSEC source: 0001093557-20-000256 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,845 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 12,568 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 4,134 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 2,951 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:11 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $439.31 | $175,724.00 |
DisclosureSEC source: 0001093557-20-000223 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,041 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| July 10, 2020 Filed Jul 14, 2020 20:27 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $439.33 | $175,732.00 |
DisclosureSEC source: 0001093557-20-000204 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,441 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 22:54 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $385.22 | $154,088.00 |
DisclosureSEC source: 0001093557-20-000187 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,841 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| May 26, 2020 Filed May 28, 2020 22:47 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,474 | $408.49 | $602,114.26 |
DisclosureSEC source: 0001093557-20-000174 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,241 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:30 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $404.05 | $161,620.00 |
DisclosureSEC source: 0001093557-20-000152 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,715 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| May 06, 2020 Filed May 13, 2020 22:30 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-20-000152 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,115 F1 · shares: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 21:18 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $279.88 | $111,952.00 |
DisclosureSEC source: 0001093557-20-000127 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,394 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 21:37 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,214 | $271.79 | $329,950.03 |
DisclosureSEC source: 0001093557-20-000113 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,794 F1 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,252 | $265.43 | $863,165.35 |
DisclosureSEC source: 0001093557-20-000099 · edgardoc.xml · nonDerivative · entry 4 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,008 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 40 | $250.20 | $10,008.11 |
DisclosureSEC source: 0001093557-20-000099 · edgardoc.xml · nonDerivative · entry 3 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,260 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 35 | $246.21 | $8,617.39 |
DisclosureSEC source: 0001093557-20-000099 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,300 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $246.2053 to $246.385. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 11, 2020 Filed Mar 14, 2020 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 60 | $245.62 | $14,737.05 |
DisclosureSEC source: 0001093557-20-000099 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,335 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $245.11 to $246.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 00:29 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 439 | $261.00 | $114,579.00 |
DisclosureSEC source: 0001093557-20-000081 · edgardoc.xml · nonDerivative · entry 2 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,395 F3 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 19,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 3,000 of which of were granted on May 22, 2016 and shall vest through May 22, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.